A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura. [electronic resource]
Producer: 20080623Description: 424-7 p. digitalISSN:- 0034-8376
- Adolescent
- Adult
- Aged
- Child, Preschool
- Combined Modality Therapy -- economics
- Drug Costs
- Drug Resistance
- Erythrocyte Transfusion
- Female
- Humans
- Immunosuppression Therapy -- economics
- Immunosuppressive Agents -- therapeutic use
- Infant
- Isoantibodies -- therapeutic use
- Male
- Middle Aged
- Opsonin Proteins -- therapeutic use
- Platelet Count
- Prospective Studies
- Purpura, Thrombocytopenic, Idiopathic -- drug therapy
- Receptors, IgG -- antagonists & inhibitors
- Remission Induction
- Rh-Hr Blood-Group System -- immunology
- Rho(D) Immune Globulin
- Splenectomy
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.